Search Results for "activate"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for activate. Results 241 to 250 of 1338 total matches.
Nedocromil for Asthma
The Medical Letter on Drugs and Therapeutics • Jul 09, 1993 (Issue 900)
as a metered-dose
inhaler for maintenance treatment of mild to moderate asthma.
ACTIVITY — A pyranoquinoline ...
Nedocromil sodium (Tilade - Fisons), an anti-inflammatory drug similar to cromolyn sodium (Intal - Fisons), although chemically unrelated, is now available in the USA as a metered-dose inhaler for maintenance treatment of mild to moderate asthma.
Imiquimod for Genital Warts
The Medical Letter on Drugs and Therapeutics • Dec 19, 1997 (Issue 1016)
factor and a variety of interleukins. Whether this cytokine cascade is responsible for its activity ...
Imiquimod (i mi kwi' mod) 5% cream (Aldara - 3M Pharmaceuticals) has been approved by the FDA for treatment of external genital and perianal warts (condyloma acuminata). The drug requires a prescription but is applied by the patient. It is the second patient-applied treatment to become available for external genital warts; the first was podofilox (Condylox - Medical Letter, 33:117, 1991).
Vazalore - A New Aspirin Formulation
The Medical Letter on Drugs and Therapeutics • May 02, 2022 (Issue 1649)
Vazalore with claims of fast, predictable
absorption and antiplatelet activity and improved ...
The FDA has approved an over-the-counter (OTC)
liquid-filled capsule formulation of aspirin (Vazalore –
PLx Pharma). The manufacturer has been heavily
promoting Vazalore with claims of fast, predictable
absorption and antiplatelet activity and improved
gastrointestinal safety compared to existing OTC
aspirin formulations.
Linaclotide (Linzess) for Functional Constipation
The Medical Letter on Drugs and Therapeutics • Aug 21, 2023 (Issue 1683)
intake, increased physical activity, and toilet
training. If first-line treatment is ineffective ...
The guanylate cyclase-C receptor agonist linaclotide
(Linzess – Abbvie/Ironwood) was first approved by
the FDA in 2012 for treatment of chronic idiopathic
constipation and irritable bowel syndrome with
constipation in adults. The drug has now been
approved for treatment of functional constipation in
patients 6-17 years old. Linaclotide is the only drug
to be approved in the US for treatment of functional
constipation.
Med Lett Drugs Ther. 2023 Aug 21;65(1683):135-6 doi:10.58347/tml.2023.1683d | Show Introduction Hide Introduction
Prevention and Treatment of Nerve Gas Poisoning
The Medical Letter on Drugs and Therapeutics • Nov 16, 1990 (Issue 831)
primarily at nicotinic sites to normalize skeletal muscle
activity. Pralidoxime itself has little activity ...
With the possibility that chemical weapons may be used against United States armed forces in the Persian Gulf, the military has taken steps to protect our troops against poison gas, particularly ''nerve agents';'; (MA Dunn and FR Sidell, JAMA, 262:649, 1989).
Felbamate
The Medical Letter on Drugs and Therapeutics • Nov 26, 1993 (Issue 910)
of seizures associated with the Lennox-Gastaut syndrome, a severe epileptic encephalopathy.
ACTIVITY ...
Felbamate (Felbatol - Wallace Laboratories), a phenyl dicarbamate structurally similar to meprobamate (Equanil, and others), was recently approved by the US Food and Drug Administration for use alone or with other drugs in adults with partial seizures with or without secondary generalization. It was also approved for use in addition to other drugs in children with the multiple types of seizures associated with the Lennox-Gastaut syndrome, a severe epileptic encephalopathy.
Nefazodone for Depression
The Medical Letter on Drugs and Therapeutics • Apr 14, 1995 (Issue 946)
Neuropharmacol, 16:S45, 1993). The clinical significance of this activity is unknown.
The Medical Letter, Vol ...
Nefazodone (Serzone - Bristol-Myers Squibb) was recently approved by the US Food and Drug Administration for treatment of depression. A phenylpiperazine, nefazodone is chemically related to trazodone (Desyrel, and others).
Two Neuraminidase Inhibitors for Treatment of Influenza
The Medical Letter on Drugs and Therapeutics • Oct 08, 1999 (Issue 1063)
−
Medical Letter, 35:109, 1993). Their use has been limited by lack of activity against influenza B, rapid ...
Zanamivir, a neuraminidase inhibitor taken by inhalation, has been approved by the FDA for treatment of influenza. Oseltamivir phosphate, an oral neuraminidase inhibitor, will probably be approved soon.
Lopinavir/Ritonavir: A Protease-inhibitor Combination
The Medical Letter on Drugs and Therapeutics • Jan 08, 2001 (Issue 1095)
is a potent inhibitor of CYP3A4 activity and raises lopinavir plasma levels. When
used in combination ...
Lopinavir/ritonavir is the first fixed-dose combination of protease inhibitors approved by the FDA for the treatment of HIV infection. It is being marketed for use with other drugs in adults and children more than six months old. Lopinavir is a new drug available only in this combination. Ritonavir is often used with other protease inhibitors to raise their plasma concentrations.
Bamlanivimab and Etesevimab for Post-Exposure Prophylaxis of COVID-19
The Medical Letter on Drugs and Therapeutics • Oct 18, 2021 (Issue 1635)
activity than bamlanivimab alone, the FDA presumed it
to be effective based on the results of BLAZE-2 Part ...
In February 2021, the FDA issued an Emergency Use
Authorization (EUA) for the investigational monoclonal
antibodies bamlanivimab and etesevimab (Lilly) for
use together to treat mild to moderate COVID-19
in persons ≥12 years old who weigh ≥40 kg and
are at high risk of progression to severe disease or
hospitalization. The FDA has now expanded this
EUA to allow use of the antibodies together for post-exposure
prophylaxis of COVID-19 in such persons
if they are not fully vaccinated against COVID-19 or
are unlikely to have an adequate immune response
to full vaccination and have...